ArticleInternational journal of oncology2022

DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions.

Chong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.